Key result
Single-dose melatonin before PPCI improves myocardial blush grade compared to standard therapy alone.
Why the study?
Myocardial reperfusion injury remains a major pitfall of PPCI, and melatonin has demonstrated protective antioxidant and radical-scavenging effects against reperfusion injury across various organs.
Does a single 3 mg oral dose of melatonin before PPCI improve microvascular integrity (MBG and TFC) in patients with acute STEMI?
RCT (n=128)
Single-blind
Odd and even number assignment
No
Does a single 3 mg oral dose of melatonin before PPCI improve microvascular integrity (MBG and TFC) in patients with acute STEMI?
Absolute Event Rate: 2.8% vs 2.3%
p-value: p=< 0.001
A single 3 mg oral dose of melatonin administered before PPCI in STEMI patients significantly improved myocardial blush grade, suggesting a potential protective effect against ischemia/reperfusion injury.
Background: One of the pitfalls of primary percutaneous coronary intervention (PPCI) is myocardial reperfusion injury caused by several pathophysiological mechanisms. Melatonin has been shown to be effective against this condition in various organs. Some of the biological effects of melatonin are associated with its capability to scavenge free radicals and reinforce the activity of antioxidant enzymes. Methods: The study population included 128 patients admitted with a diagnosis of acute ST-elevation myocardial infarction (STEMI) to the Emergency Department of Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, who subsequently underwent PPCI. The patients were randomly assigned to two groups, each consisting of 64 cases, with those receiving 3 mg of melatonin in the emergency department before adding PPCI to the standard treatment (test group) and those receiving the standard therapy alone (control group). The myocardial blush grade (MBG) and thrombolysis in myocardial infarction frame count were assessed visually on the angiogram to evaluate microvascular integrity. Results: In the study as a whole and in subgroup analysis, the MBG showed a significant difference with melatonin prescription (2.8 ± 0.3 and 2.3 ± 0.7 in the test and control groups, respectively; P < 0.001). In patients with coronary risk factors, no difference was observed between the two groups. Nevertheless, melatonin significantly improved the MBG in patients without such risk factors. Melatonin had significant protective effects in both the right coronary and left anterior descending culprit arteries. Conclusions: This study demonstrated the effect of melatonin on preventing reperfusion injury in patients with STEMI undergoing PPCI.
No takes yet. Share an insight, caveat, or question.
Eslami et al. (2023) conducted an RCT in Acute ST-elevation myocardial infarction (STEMI) (n=128). Melatonin vs. Standard therapy alone was evaluated on Myocardial blush grade (MBG) (p=< 0.001). A single 3 mg oral dose of melatonin administered before primary percutaneous coronary intervention significantly improved myocardial blush grade compared to standard therapy alone (2.8 vs 2.3, P < 0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: